Share tips of the week – 14 January
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
4Global
The Mail on Sunday
4Global helps cities and organisations arrange and profit from sporting events. The firm has worked on “virtually every summer and winter Olympic Games”, from London to Tokyo, as well as World Cups and other football championships. Over the last few months alone it secured a £4m contract with Sport England, a £370,000 contract with the Peruvian government, and a deal with the city of Los Angeles to “maximise the legacy of the 2028 Olympic Games”. It has a pipeline of contracts worth over £100m over the next four years, and profits are expected to more than triple to £1.1m for the year to March 2023 from £325,000 this year. Buy in now. 84p.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Medtronic
The Daily Telegraph
US-listed Medtronic isn’t a household name, but its products play a big part in the lives of many people. The firm makes devices such as insulin pumps and defibrillators. Its shares have underperformed for three years, initially because it seemed to be losing market share and recently because Covid-19 has caused delays to elective surgeries. But a new CEO should get growth back on track after the pandemic. The shares are cheap, assuming a forecast free cash flow yield of 4.5%-5% and high single-digits growth. $106.39.
Amgen
Motley Fool
Biotech giant Amgen’s stock fell slightly over the last year, but thanks to an increase in its dividend and the “market wide pivot to large-cap stocks among investors”, its stock has gained 13.2% from the start of December. That “ought to continue for the remainder of the year”, helped by the FDA’s approval of its lung cancer treatment last May. $229.20.
Three to sell
Aston Martin
The Sunday Times
No Time to Die, the latest James Bond film, featured “no fewer than four Aston Martin models”, including the carmaker’s latest offering, the Valhalla. This £700,000 plug-in electric hybrid is set to launch in 2023 and only 1,000 will be made. But the company “has more immediate concerns”. Profits for the financial year to December 2021 are set to be £15m below expectations due to sluggish deliveries of the Valkyrie, its £2.5m “flagship hypercar”. Sell now. 1,452p.
Wood Group
The Sunday Telegraph
Investors who purchased shares in energy-services specialist Wood Group over the last few years “are likely to be deeply in the red”: the shares have lost 76% of their value over the last five years. First-half revenue for the six months to June 2021 fell 23% compared to the same period the year before, and its latest trading update “included a downward revision to revenue and profit”. Debt is also expected to be higher than anticipated. Avoid. 206.5p.
Robinhood Markets
Forbes
Shares in discount-brokerage firm Robinhood began trading at $35 when the company floated in July, and peaked at $85 a week later. They have now plunged around 80%. The biggest problem is its reliance on users trading cryptocurrencies: the shares dropped after its third-quarter report showed revenue fell “way short of expectations” due to reduced activity. Accounts also dropped 4% to 22.4 million, monthly active users fell 11% to 18.9 million, and average revenue per user fell 36% to $65. The firm expects “seasonal headwinds and lower retail trading” in its December update. Avoid. $16.
...and the rest
The Daily Telegraph
Naked Wines has reinvented itself from a chain of wine warehouses to a promising online wine business. Sales growth has fallen from last year and the company is suffering from supply chain problems, but it has a “well defined and differentiated strategy”. However, real profitability “lies in the future”, making it difficult to value. Hold. 602p. Videogames company Team17 benefitted from the pandemic as more people sought out entertainment at home. Its latest trading update revealed sales and profits are set to be ahead of expectations and better than in 2020. Keep holding. 800p.
The Mail on Sunday
Made Tech helps the public sector use technology better. Revenues doubled last year, then soared 131% to £11.7m in the six months to November. Expect it to win more contracts from central government and local authorities (112p). Medica provides teleradiology services, allowing the NHS to share scans quickly among specialists. Demand fell in 2020 as hospitals focused on Covid-19, but its services will be even more important as they try to clear their backlog. Sales are expected to rise 66% to £61m this year and profits to double to £10.3m. Solid cash flow should let it pay a 2.6p dividend. 163p. Hornby makes train sets, as well as owning the Scalextric, Airfix and Corgi toy brands. The business has been transformed since the current CEO took over in 2017. It was hit by supply-chain issues last summer, but demand is robust in the UK and overseas. The stock should recover strongly from here. 42p. Ideagen’s software helps organisations comply with regulations. Its market is fragmented with plenty of opportunity for growth through acquisitions. Buy. £2.70.
-
Private school fees soar and VAT threat looms – what does it mean for you?
Rising private school fees could see more than one in five parents pull their children out of their current school. Before you remortgage, move house or look to grandparents for help, here’s what you need to know.
By Katie Williams Published
-
Best and worst UK banks for online banking revealed
When it comes to keeping your money safe, not all banks are equal. We reveal the best and worst banks for online banking when it comes to protecting your money from scams
By Oojal Dhanjal Published
-
AstraZeneca CEO’s £1.8mn pay rise approved despite shareholder opposition
AstraZeneca hiked its dividend to persuade shareholders to accept CEO Pascal Soriot’s pay rise. Is he worth his salary?
By Dr Matthew Partridge Published
-
Adidas, Nike or Jordans - could collectable trainers make you rich?
The right pair of trainers can fetch six figures. Here's how you can start collecting vintage Adidas, Nike or Jordans now
By Chris Carter Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published